About
Small Molecule Cancer Drugs
Areas of Focus
Categories
Small Molecule PharmaceuticalNJ, NY, PA
Clinical Trials (14)
View allTotal Trials
14
As Lead Sponsor
12
As Collaborator
2
Total Enrollment
924
By Phase
PHASE1: 4PHASE1/PHASE2: 7PHASE2: 2PHASE3: 1
By Status
COMPLETED: 8TERMINATED: 3RECRUITING: 2UNKNOWN: 1
Clinical Trials Pipeline14 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT06260514Lead Sponsor
Study of APR-1051 in Patients With Advanced Solid Tumors
PHASE1Recruiting
79 participants
Started: Jun 13, 2024 · Completed: Jun 30, 2028
NCT04905914Lead Sponsor
Study Of ATRN-119 In Patients With Advanced Solid Tumors
PHASE1/PHASE2Recruiting
132 participants
Started: Jan 9, 2023 · Completed: Feb 29, 2028
NCT04638309Lead Sponsor
APR-548 in Combination With Azacitidine for the Treatment of TP53 Myelodysplastic Syndromes (MDS)
PHASE1Terminated
4 participants
Started: Sep 20, 2021 · Completed: Apr 25, 2022
NCT04419389Lead Sponsor
APR-246 in Combination With Acalabrutinib or Venetoclax Based Therapy in Subjects With R/R Non Hodgkin Lymphomas (NHL)
PHASE1/PHASE2Terminated
1 participants
Started: Mar 2, 2021 · Completed: Aug 24, 2021
NCT04383938Lead Sponsor
Phase 1/2 Study of APR-246 in Combination With Pembrolizumab in Subjects With Solid Tumor Malignancies
PHASE1/PHASE2Completed
40 participants
Started: Jun 25, 2020 · Completed: Apr 30, 2022
Locations (1)
Headquarters
Doylestown, PA, United States
Map
Loading map...